Mirae Asset Global ETFs Holdings’s Beam Therapeutics BEAM Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.39M	Buy	156,997 +38,979	+33%	+$1.18M	0.01%	833
2026 Q1	$2.79M	Buy	118,018 +5,247	+5%	+$146K	﹤0.01%	1040
2025 Q4	$3.13M	Buy	112,771 +4,090	+4%	+$104K	﹤0.01%	967
2025 Q3	$2.64M	Sell	108,681 -8,765	-7%	-$174K	﹤0.01%	1022
2025 Q2	$2M	Sell	117,446 -49,568	-30%	-$863K	﹤0.01%	1101
2025 Q1	$3.28M	Buy	167,014 +4,607	+3%	+$121K	0.01%	894
2024 Q4	$4.03M	Buy	162,407 +6,128	+4%	+$156K	0.01%	845
2024 Q3	$3.83M	Sell	156,279 -17,901	-10%	-$462K	0.01%	850
2024 Q2	$4.08M	Buy	+174,180	New	+$4.28M	0.01%	812

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's BEAM Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Beam Therapeutics (BEAM) stake by 33% in Q2 2026, buying an estimated $1.18M and bringing the position to 156,997 shares worth $5.39M. The position accounts for 0.01% of the portfolio, ranked #833.

Mirae Asset Global ETFs Holdings first reported a position in BEAM in Q2 2024 and has held it in 9 quarters since. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

Mirae Asset Global ETFs Holdings held 156,997 shares of Beam Therapeutics worth $5.39M as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 38,979 Beam Therapeutics shares in Q2 2026, an estimated $1.18M.
Beam Therapeutics made up 0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #833 holding.
Mirae Asset Global ETFs Holdings first reported a position in Beam Therapeutics in Q2 2024 and has held it in 9 quarters since.
277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.